Amyloid-beta42 plasma levels are elevated in amnestic mild cognitive impairment

Autor: Valeria Pollero, Roberta Borghi, Patrizio Odetti, Michele Fornaro, Matteo Pardini, Sergio Cammarata, Luca Giliberto, Massimo Tabaton, Cristina Novello, Antonella Vitali, Carlo Caltagirone, Laura Bracco, Paola Bossù
Přispěvatelé: Cammarata, Sergio, Borghi, Roberta, Giliberto, Luca, Pardini, Matteo, Pollero, Valeria, Novello, Cristina, Fornaro, Michele, Vitali, Antonella, Bracco, Laura, Caltagirone, Carlo, Bossù, Paola, Odetti, Patrizio, Tabaton, Massimo
Jazyk: angličtina
Rok vydání: 2009
Předmět:
Popis: Amnestic mild cognitive impairment (aMCI) is considered a prodromal stage of Alzheimer's disease (AD). We measured plasma levels of amyloid-beta40 (Abeta40) and Abeta42 in 191 subjects with aMCI. Seventy-nine of them were clinically followed for two years. In the total cohort of aMCI cases, the average level of Abeta42, as well as the Abeta42/Abeta40 ratio, was significantly higher than those of the 102 cognitively normal age-matched subjects. The aMCI cases that converted to probable AD within 2 years had higher levels of Abeta42 and, to a lesser extent, Abeta40 than the stable cases. However the large variability of measured values indicates that plasma Abeta is not a suitable marker of incipient AD.
Databáze: OpenAIRE